**Plasmapheresis Regulation to be Discussed by House Health Committee in October**
The House health committee in Cyprus is set to address the regulation of plasmapheresis, a medical procedure that has recently sparked public interest and debate. The discussion is scheduled for October, as confirmed by Savia Orphanidou, the head of the committee and a member of the Democratic Rally party (Disy).
Orphanidou announced on Thursday that the committee has registered the issue ex officio, indicating that it will proactively evaluate the current regulatory framework surrounding plasmapheresis. This procedure, which involves the removal of plasma from the blood, is used to treat various medical conditions, but its regulation has come under scrutiny.
The upcoming discussions will focus on several critical aspects of plasmapheresis, including the necessary checks that must be conducted in health centers and hospitals licensed to perform the procedure. Additionally, the committee will examine the licensing requirements for health professionals who administer plasmapheresis and the standards for the medical equipment utilized in these procedures.
Orphanidou emphasized the importance of ensuring that appropriate regulations are in place to safeguard patient health and enhance the quality of care provided by health facilities. “On behalf of the entire health committee, we have registered the issue,” she stated, underscoring the committee's commitment to addressing public concerns regarding the practice.
This initiative aligns with a broader effort by the Ministry of Health, which has recently begun mapping high-risk medical centers that perform various procedures, including plasmapheresis. The mapping project aims to identify and evaluate the capabilities and compliance of health facilities across the country.
As the discussion approaches, stakeholders in the medical community and the public are encouraged to stay informed about the developments surrounding plasmapheresis regulation and the implications for healthcare practices in Cyprus. The upcoming committee meeting is expected to provide a platform for dialogue and contribute to the establishment of a comprehensive regulatory framework that ensures patient safety and effective medical treatment.